- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02538887
Use of a Supplemental Radiofrequency Detection System Subsequent to Manual Counting of Vaginal Textiles Following Vaginal Birth
November 3, 2020 updated by: The University of Texas Health Science Center, Houston
Use of a Supplemental Radiofrequency Detection System Subsequent to Manual Counting of Vaginal Textiles Following Vaginal Birth: A Prospective Effectiveness and Efficiency Study For Sponge Tracking
The purpose of this study is to evaluate the FDA-approved Radio Frequency Surgical Detection System (RFDS) as a non-radiological means to ease the process of detecting retained sponges and reconciling sponge counts in the labor and delivery room (following vaginal birth).
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
This study proposes to evaluate the FDA-approved Radio Frequency Surgical Detection System (RFDS) as a non-radiological means to ease the process of detecting retained sponges and reconciling sponge counts in the labor and delivery room (following vaginal birth).
It would not replace any of the current standard-of-care safety mechanisms already in place at the study site to prevent retained sponges.
All safeguards remain enforced: counting, visual inspection, and x-rays if indicated by standard protocol.
The system being studied involves the surgeon scanning the subject's vaginal area using a spherical device placed 1cm above the symphysis pubis.
This static scan will serve to detect any retained cotton textiles within the vaginal cavity after birth.
This Verisphere, a reusable device, is encased in a sterile sheath during use.
It does not come into direct contact with the subject's vagina, but hovers above the pelvic/vaginal region.
If any radio-frequency tagged sponges remain inside the subject, a signal alerts the surgical team to remove them.
The visible console displays a confirmation code once the scan is complete.
This confirmation code is kept as part of the medical record once absence of retained textiles is confirmed.
Once the provider is assured there is no retained item, the same device may be used to scan trash receptacles to locate a missing textile if the pre- and post-delivery sponge/gauze count remains incongruent.
This alleviates the need for the assistant personnel to manually "dig" through soiled materials for sponge localization.
Study Type
Observational
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
All subjects will be inpatients at UTHealth/Memorial Hermann Hospital (and affiliates) who are awaiting vaginal birth.
Subjects will be identified upon admittance to Labor and Delivery triage.
Description
Inclusion Criteria:
- Adults only, 18 years or older
- Admitted as inpatients to labor and delivery; patients must be in anticipation of vaginal delivery
Exclusion Criteria:
- Urgent or emergent admissions under the influence of preoperative medication, drugs or alcohol.
- Age less than 18 years,
- The patient does not understand English well enough to adequately understand the study.
- Hesitancy of the patient to participate or family reluctance based on the study doctor's opinion.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Radio Frequency Surgical Detection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of patients for whom surgical sponge counts can't be reconciled
Time Frame: at the time of radio frequency surgical detection
|
at the time of radio frequency surgical detection
|
Number of patients for whom an X-ray was required
Time Frame: at the time of radio frequency surgical detection
|
at the time of radio frequency surgical detection
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Teresa Byrd, MD, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 1, 2015
Primary Completion (Anticipated)
May 1, 2016
Study Completion (Anticipated)
May 1, 2016
Study Registration Dates
First Submitted
August 31, 2015
First Submitted That Met QC Criteria
August 31, 2015
First Posted (Estimate)
September 2, 2015
Study Record Updates
Last Update Posted (Actual)
November 5, 2020
Last Update Submitted That Met QC Criteria
November 3, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- HSC-MS-15-0535
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Radio Frequency Surgical Detection
-
Johns Hopkins UniversityTerminatedPersistent Atrial FibrillationUnited States
-
Alma LasersWithdrawn
-
Abbott Medical DevicesCompletedVentricular Outflow Tract Tachycardia
-
Haukeland University HospitalUniversity Hospital of North Norway; St. Olavs HospitalNot yet recruitingAtrial Fibrillation, Persistent | Atrial Fibrillation Recurrent
-
Karolinska University HospitalRecruitingAtrial FibrillationSweden
-
Broncus Medical IncUptake Medical Technology, Inc.TerminatedLung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small CellChina
-
The Alfred E. Mann Foundation for Scientific ResearchVA Office of Research and DevelopmentCompletedHemiparesisUnited States
-
Oslo University HospitalUniversity Hospital of North Norway; Haukeland University Hospital; St. Olavs...RecruitingPancreatic Neuroendocrine Tumors, WHO Grade I-IINorway
-
The Alfred E. Mann Foundation for Scientific ResearchWalter Reed Army Medical CenterTerminatedSpinal Cord Injury at C5-C7 Level With Incomplete LesionUnited States
-
Asian Institute of Gastroenterology, IndiaRecruitingBile Duct Neoplasms | Gall Bladder CarcinomaIndia